Royal Bank of Canada’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$148K Sell
75,243
-33,169
-31% -$77.8K ﹤0.01% 4900
2025
Q4
$294K Buy
108,412
+89,176
+464% +$293K ﹤0.01% 4523
2025
Q3
$82K Sell
19,236
-5,445
-22% -$23.9K ﹤0.01% 5605
2025
Q2
$124K Sell
24,681
-26,285
-52% -$114K ﹤0.01% 5501
2025
Q1
$226K Sell
50,966
-6,125
-11% -$28.7K ﹤0.01% 4605
2024
Q4
$266K Buy
57,091
+26,587
+87% +$146K ﹤0.01% 4577
2024
Q3
$211K Buy
30,504
+14,190
+87% +$111K ﹤0.01% 4776
2024
Q2
$127K Sell
16,314
-759
-4% -$5.62K ﹤0.01% 5115
2024
Q1
$121K Sell
17,073
-29,983
-64% -$198K ﹤0.01% 5077
2023
Q4
$315K Buy
47,056
+1,454
+3% +$8.19K ﹤0.01% 4682
2023
Q3
$257K Sell
45,602
-5,817
-11% -$38.8K ﹤0.01% 4582
2023
Q2
$283K Sell
51,419
-559
-1% -$3.01K ﹤0.01% 4442
2023
Q1
$325K Sell
51,978
-7,162
-12% -$39.9K ﹤0.01% 4220
2022
Q4
$276K Buy
59,140
+6,074
+11% +$29.9K ﹤0.01% 4603
2022
Q3
$248K Sell
53,066
-11,522
-18% -$72.6K ﹤0.01% 4584
2022
Q2
$382K Sell
64,588
-58,027
-47% -$646K ﹤0.01% 4295
2022
Q1
$2.37M Buy
122,615
+10,995
+10% +$252K ﹤0.01% 2908
2021
Q4
$3.65M Sell
111,620
-100,829
-47% -$4.06M ﹤0.01% 2620
2021
Q3
$8.71M Sell
212,449
-11,589
-5% -$420K ﹤0.01% 1922
2021
Q2
$8.07M Sell
224,038
-2,621
-1% -$96.7K ﹤0.01% 1953
2021
Q1
$8.85M Buy
226,659
+58,886
+35% +$2.65M ﹤0.01% 1838
2020
Q4
$6.77M Buy
167,773
+158,555
+1,720% +$7.28M ﹤0.01% 1984
2020
Q3
$513K Buy
+9,218
New +$488K ﹤0.01% 3828

Other funds holding GDRX

Royal Bank of Canada's GDRX Position: Q1 2026 in Review

Royal Bank of Canada reduced its GoodRx Holdings (GDRX) stake by 31% in Q1 2026, selling an estimated $77.8K and leaving 75,243 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #4900.

Royal Bank of Canada first reported a position in GDRX in Q3 2020 and has held it in 23 quarters since. The position peaked at $8.85M in Q1 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Royal Bank of Canada held 75,243 shares of GoodRx Holdings worth $148K as of Q1 2026.
  • Royal Bank of Canada sold 33,169 GoodRx Holdings shares in Q1 2026, an estimated $77.8K.
  • GoodRx Holdings made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #4900 holding.
  • Royal Bank of Canada first reported a position in GoodRx Holdings in Q3 2020 and has held it in 23 quarters since.
  • Royal Bank of Canada's GoodRx Holdings position peaked at $8.85M in Q1 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.